APA

Donzel-Javouhey A., Thauvin-Robinet C., Cusin V., Madinier N., Manceau E., Dipanda D., Dulieu V., Mugneret F., Huet F., Teyssier J. & Faivre L. (20060928). A new cohort of MECP2 mutation screening in unexplained mental retardation: careful re-evaluation is the best indicator for molecular diagnosis. : American journal of medical genetics. Part A.

Chicago

Donzel-Javouhey Anne, Thauvin-Robinet Christel, Cusin Veronica, Madinier Nathalie, Manceau Eric, Dipanda Dominique, Dulieu Véronique, Mugneret Francine, Huet Frédéric, Teyssier Jean-Raymond and Faivre Laurence. 20060928. A new cohort of MECP2 mutation screening in unexplained mental retardation: careful re-evaluation is the best indicator for molecular diagnosis. : American journal of medical genetics. Part A.

Harvard

Donzel-Javouhey A., Thauvin-Robinet C., Cusin V., Madinier N., Manceau E., Dipanda D., Dulieu V., Mugneret F., Huet F., Teyssier J. and Faivre L. (20060928). A new cohort of MECP2 mutation screening in unexplained mental retardation: careful re-evaluation is the best indicator for molecular diagnosis. : American journal of medical genetics. Part A.

MLA

Donzel-Javouhey Anne, Thauvin-Robinet Christel, Cusin Veronica, Madinier Nathalie, Manceau Eric, Dipanda Dominique, Dulieu Véronique, Mugneret Francine, Huet Frédéric, Teyssier Jean-Raymond and Faivre Laurence. A new cohort of MECP2 mutation screening in unexplained mental retardation: careful re-evaluation is the best indicator for molecular diagnosis. : American journal of medical genetics. Part A. 20060928.